top of page
Interview

In the Press

Read the latest press releases from Biox Medical & keep up to date nationally and internationally

Discover the lasted Cancer Preventative technologies with the safest and most reliable distribution services with Biox Medical.

Also available at 

Hereditary Cancer Panel comprehensive multi-cancer panel to targeted panels for breast, ovarian, colorectal, prostate, melano
APC, ATM1, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, CDKN2A, CHEK22, EPCAM3, HOXB13, MLH1, MSH2, MSH6, MUTYH, NF1
images.jfif
ATM1, BARD1, BRCA1, BRCA2, CHEK22, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53

AT HOME LAB TEST FOR EARLY CANCER DETECTION ,DELIVERED ON DEMAND

ATM1, BARD1, BRCA1, BRCA2, BRIP1, CHEK22, EPCAM3, MLH1, MSH2, MSH6, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53

Image Gallery

There may be no better way to communicate what we do than through images. As you browse our site, take a few moments to let your eyes linger here, and see if you can get a feel for our signature touch.

"BEST FOR PEACE OF MIND"

The team of HCPC registered clinical scientists at Informed Genomics will interpret your test results in accordance to well r

"ColoAlert goes further than the free, at-home NHS kits"

How IGL we Interpret genetic variants? At Informed Genomics, genetic variants are interpreted using the following methods:

"Non-invasive bowel cancer test catches illness early"

What are variants of unknown significance (VUS)? Variants of unknown significance are variants where there is either insuffi

"Only one in Europe to combine FIT`s capabilities with DNA markers in stools"

A genetic cause is suspected when the clinical features or family history include the following, in which case a hereditary c

As seen in the media

ColoAlert® is an award-winning next-generation colorectal cancer home screening test "
 

Our hereditary cancer clinical service at Informed Genomics aims to identify individuals at a higher-than-population risk for
bottom of page